Majer I - Search Results

1

Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

Kastritis E, Ntanasis-Stathopoulos I, Theodorakakou F, Migkou M, Roussou M, Malandrakis P, Kanellias N, Eleutherakis-Papaiakovou E, Fotiou D, Spiliopoulou V, Gavriatopoulou M, Patel S, Majer I, Boukis C, Fetani A, Dimopoulos MA, Terpos E. Kastritis E, et al. Among authors: majer i. Clin Lymphoma Myeloma Leuk. 2024 Mar 19:S2152-2650(24)00110-1. doi: 10.1016/j.clml.2024.03.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38616479 Free article.

2

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.

Weisel K, Dimopoulos MA, Beksac M, Leleu X, Richter J, Heeg B, Patel S, Majer I, McFadden I, Mikhael J. Weisel K, et al. Among authors: majer i. Leuk Lymphoma. 2024 Apr;65(4):481-492. doi: 10.1080/10428194.2023.2300051. Epub 2024 Feb 12. Leuk Lymphoma. 2024. PMID: 38345269 Clinical Trial.

3

Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France.

Caillon M, Brethon B, van Beurden-Tan C, Supiot R, Le Mezo A, Chauny JV, Majer I, Petit A. Caillon M, et al. Among authors: majer i. Pharmacoecon Open. 2023 Jul;7(4):639-653. doi: 10.1007/s41669-023-00411-4. Epub 2023 Apr 18. Pharmacoecon Open. 2023. PMID: 37071263 Free PMC article.

4

Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma.

Majer I, Kroep S, Maroun R, Williams C, Klijn S, Palmer S. Majer I, et al. Value Health. 2022 Apr;25(4):595-604. doi: 10.1016/j.jval.2021.09.011. Epub 2021 Nov 3. Value Health. 2022. PMID: 35365303 Free article.

5

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.

MacEwan JP, Majer I, Chou JW, Panjabi S. MacEwan JP, et al. Among authors: majer i. Ther Adv Hematol. 2021 Jul 3;12:20406207211027463. doi: 10.1177/20406207211027463. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34276923 Free PMC article.

6

Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden.

Nahi H, Walinder G, Patel V, Qu Y, Levine A, Majer I, Kutikova L, Hellqvist Franck E, Svensson MK, Hansson M. Nahi H, et al. Among authors: majer i. Acta Haematol. 2021;144(5):519-527. doi: 10.1159/000512165. Epub 2021 Feb 25. Acta Haematol. 2021. PMID: 33631745 Free PMC article.

7

Predictions for Z-Boson Production in Association with a b-Jet at O(α_{s}^{3}).

Gauld R, Ridder AG, Glover EWN, Huss A, Majer I. Gauld R, et al. Among authors: majer i. Phys Rev Lett. 2020 Nov 27;125(22):222002. doi: 10.1103/PhysRevLett.125.222002. Phys Rev Lett. 2020. PMID: 33315443

8

TREM-1 and TREM-2 Expression on CD14⁺ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response.

Suchankova M, Urban J, Ganovska M, Tibenska E, Szaboova K, Tedlova E, Sandor F, Majer I, Bobovcak M, Jonner I, Konig B, Bucova M. Suchankova M, et al. Among authors: majer i. Mediators Inflamm. 2020 May 14;2020:9501617. doi: 10.1155/2020/9501617. eCollection 2020. Mediators Inflamm. 2020. PMID: 32508528 Free PMC article.

9

Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States.

Kumar SK, Majer I, Panjabi S, Medhekar R, Campioni M, Dimopoulos MA. Kumar SK, et al. Among authors: majer i. Expert Rev Hematol. 2020 Jun;13(6):687-696. doi: 10.1080/17474086.2020.1746639. Epub 2020 Apr 6. Expert Rev Hematol. 2020. PMID: 32249621

10

Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air^® App.

Bédard A, Antó JM, Fonseca JA, Arnavielhe S, Bachert C, Bedbrook A, Bindslev-Jensen C, Bosnic-Anticevich S, Cardona V, Cruz AA, Fokkens WJ, Garcia-Aymerich J, Hellings PW, Ivancevich JC, Klimek L, Kuna P, Kvedariene V, Larenas-Linnemann D, Melén E, Monti R, Mösges R, Mullol J, Papadopoulos NG, Pham-Thi N, Samolinski B, Tomazic PV, Toppila-Salmi S, Ventura MT, Yorgancioglu A, Bousquet J, Pfaar O, Basagaña X; MASK study group. Bédard A, et al. Allergy. 2020 Jul;75(7):1672-1688. doi: 10.1111/all.14204. Epub 2020 Mar 22. Allergy. 2020. PMID: 31995656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page